CONFIDENTIAL SUPPLY AGREEMENT Dated December 13, 2006Supply Agreement • December 22nd, 2006 • Stellar Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS SUPPLY AGREEMENT is dated and made effective as of December 12th, 2006, (the "Effective Date") by and between STELLAR PHARMACEUTICALS INC., a corporation organized under the laws of the Province of Ontario, and having a principal place of business at 544 Egerton Street, London Ontario Canada N5W 3Z8 ("Stellar"), and WATSON PHARMA, INC, a corporation organized under the laws of the State of Delaware, United States of America, with its corporate headquarters located at 360 Mount Kemble Avenue, Morristown, New Jersey United States of America 07962-1953 ("Watson") (each individually a "Party" and collectively the "Parties").
LICENSE AGREEMENT This License Agreement made as of December 13, 2006 BETWEENLicense Agreement • December 22nd, 2006 • Stellar Pharmaceuticals Inc • Pharmaceutical preparations • New York
WHEREAS Stellar has developed and owns Methods and Technical Know-How (as such terms are hereinafter defined) relating to the manufacture and use of its proprietary product Uracyst®, a sterile sodium chondroitin sulphate solution for human use,
